From 2013 to 2022, the Broad Institute ran the Science For All Seasons series, which gave audiences the opportunity to explore hot topics in genomics with leading experts from Broad. Here you will find archived talks from the series's 10-year run. For new talks from Broad, we encourage you to follow the Broad Discovery Series.
Tuesday, August 2, 5:00-6:00pm
What will it take to make clinical genomics part of everyday medicine?
The first human genome cost $2.7 billion and took nearly 20 years to complete. Labs around the world now sequence genomes everyday for a fraction of the time and cost. Clinical geneticist Heidi Rehm will discuss how researchers and clinicians are working together to leverage all of those data to change the lives of millions of patients and find the causes for some of the rarest diseases.
This lecture is presented in memory of Eliana Hechter and is supported by the Eliana Hechter Memorial Fund.
Soon after losing her mother to genetic prion disease in 2010, Sonia Vallabh and her husband, Eric Minikel, learned that Sonia had inherited a mutation that put her at high risk for this progressive, degenerative, and currently untreatable disorder. The result upended their lives, and launched them on a now decade-long journey to understand the roots of prion disease and, hopefully, find a way to prevent it before it strikes. Along the way, they have helped redefine the nature of prion disease, and built a community of scientists, patients, and families that is walking the path with them.
Tuesday, February 15, 5:00-6:00pm
Count Me In: How engaging patients can accelerate cancer research
Nikhil Wagle, Elana Anastasio, and Colleen Nguyen
In the United States alone, nearly 2 million people were diagnosed with cancer last year. Only a fraction of them, though, will have the opportunity to participate in research that could benefit them or others like them. Join Nikhil Wagle, Elana Anastasio, and Colleen Nguyen as they talk about Count Me In, a project that engages patients everywhere in the US and Canada diagnosed with any kind of cancer, and enables them to accelerate cancer research by sharing their samples, their clinical information, and their voices.